← Back to Search

Behavioral Intervention

Sense2Quit App for Smoking Cessation in HIV

N/A

Waitlist Available

Led By Rebecca Schnall, PhD, MPH

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks after baseline (or quit date if later than baseline visit)

Awards & highlights

Study Summary

This trial tests if a mobile app helps people living with HIV quit smoking.

Who is the study for?

This trial is for people living with HIV who smoke, are at least 18 years old, own an Android smartphone, and can understand English. They should be willing to quit smoking within a month and not currently using any nicotine replacement or other smoking cessation aids. Pregnant or breastfeeding individuals cannot participate.Check my eligibility

What is being tested?

The Sense2Quit App is being tested in this study to see if it's feasible and effective for helping people living with HIV to stop smoking. The trial will involve 60 participants who will use the app as part of a pilot randomized controlled trial.See study design

What are the potential side effects?

Since this trial involves the use of an app for smoking cessation, there may not be direct side effects from the intervention itself; however, quitting smoking can lead to withdrawal symptoms such as irritability, cravings, and difficulty concentrating.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks after baseline (or quit date if later than baseline visit)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks after baseline (or quit date if later than baseline visit)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks after baseline (or quit date if later than baseline visit) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of Participants With Biochemically Verified 7-day Point Prevalence Smoking/Tobacco Abstinence

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention (App Arm)Experimental Treatment1 Intervention

Participants randomized to the intervention arm will receive access to the Sense2Quit App (A multi-component intervention that links a smartphone app to a smartwatch to provide real-time quit reminders to curtail relapses and avoid potential triggers), standard smoking cessation counseling, and nicotine replacement therapy.

Group II: ControlActive Control1 Intervention

Participants randomized to the control arm will receive standard smoking cessation counseling and referral to quitline.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,431 Previous Clinical Trials

2,460,771 Total Patients Enrolled

Case Western Reserve UniversityOTHER

299 Previous Clinical Trials

259,960 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,933,093 Total Patients Enrolled

Media Library

Sense2Quit App (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05609032 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: Intervention (App Arm), Control

Human Immunodeficiency Virus Infection Clinical Trial 2023: Sense2Quit App Highlights & Side Effects. Trial Name: NCT05609032 — N/A

Sense2Quit App (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05609032 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research project currently facilitating enrolment of participants?

"Affirmative. Clinicaltrials.gov's information demonstrates that, as of 1/1/2023 this medical trial is actively seeking participants to enrol in its program. The study was last updated on 11/4/2022 and requires 60 volunteers from a single site."

Answered by AI

What is the volume of participants currently enrolled in this clinical experiment?

"Correct. Details on clinicaltrials.gov verify that this research trial is still actively looking for participants; it was first published on the 1st of January 2023 and most recently updated on November 4th 2022. The medical centre needs to enlist 60 individuals in total from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Development and Pilot Testing of the Sense2Quit App

Rebecca Schnall, RN, MPH, PhD 2023. "Development and Pilot Testing of the Sense2Quit App". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05609032.